Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Titan Medical Inc.

Healthcare US TMDIF

NoneUSD
0.00(0%)

Last update at 2024-11-14T21:00:26.371909Z

Day Range

--
LowHigh

52 Week Range

0.051.20
LowHigh

Fundamentals

  • Previous Close 0.82
  • Market Cap6.49M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.33400M
  • Revenue TTM17.13M
  • Revenue Per Share TTM0.15
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.32

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -42.59800M -14.80200M -24.18466M -41.90708M
Minority interest - - - -
Net income -42.54200M -14.85800M -24.18466M -41.90708M
Selling general administrative 11.76M 12.43M 7.63M 7.81M
Selling and marketing expenses - - - -
Gross profit - - - -
Reconciled depreciation 0.86M 0.70M 0.24M 0.03M
Ebit - -30.30900M 4.15M -59.26600M
Ebitda -41.59100M -13.97800M -22.85660M -41.45153M
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -44.77100M -30.98700M 4.20M -59.26532M
Other operating expenses - - - -
Interest expense 0.15M 0.12M 1.09M 0.42M
Tax provision -0.05600M 0.06M - -
Interest income 0.14M 0.07M 0.03M 0.12M
Net interest income -0.00300M -0.05200M -2.87839M -2.40444M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - 0.06M - -
Total revenue 0.00000M 20.09M 20.00M 0.00000M
Total operating expenses 44.77M 51.08M 15.80M 59.27M
Cost of revenue - - - -
Total other income expense net 2.18M 16.24M -25.50301M 19.76M
Discontinued operations - - - -
Net income from continuing ops -42.54200M -14.85800M -24.18466M -41.90708M
Net income applicable to common shares - -14.85800M -24.18400M -41.90700M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 7.12M 47.22M 29.84M 3.38M
Intangible assets 2.08M 1.92M 1.78M 1.60M
Earning assets - - - -
Other current assets - - - 0.48M
Total liab 10.28M 11.93M 43.65M 15.06M
Total stockholder equity -3.16400M 35.29M -13.80949M -11.68183M
Deferred long term liab - - - -
Other current liab 0.28M 4.93M 36.32M 3.62M
Common stock - 263.36M 215.15M 194.86M
Capital stock 264.51M 263.36M 215.82M 194.86M
Retained earnings -296.42900M -253.88700M -239.02900M -214.84477M
Other liab - 0.06M - -
Good will - - - -
Other assets - - - -
Cash 3.29M 32.31M 25.47M 0.81M
Cash and equivalents - - - -
Total current liabilities 8.86M 10.89M 42.90M 15.06M
Current deferred revenue - - - -
Net debt - - - -
Short term debt - - - -
Short long term debt - - 1.89M -
Short long term debt total - - - -
Other stockholder equity - 11.75M 0.67M -
Property plant equipment - 1.64M 1.11M 0.03M
Total current assets 5.04M 43.66M 26.95M 1.75M
Long term investments - - - -
Net tangible assets - 33.37M -15.58700M -13.28358M
Short term investments - - - -
Net receivables 0.00000M 8.28M 0.07M 0.08M
Long term debt - - - -
Inventory - - - -
Accounts payable - 5.62M 4.53M 10.85M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total 2.08M 3.56M 2.89M 1.63M
Capital lease obligations 1.71M 1.33M 0.92M 0.03M
Long term debt total - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -1.02000M -0.75500M -0.59937M -0.45804M
Change to liabilities - 1.09M -4.37100M 4.96M
Total cashflows from investing activities - -0.75500M -0.59900M -0.45800M
Net borrowings - 0.03M 1.41M -0.00500M
Total cash from financing activities -0.41900M 44.21M 26.10M 35.76M
Change to operating activities - -1.59700M -0.54400M 8.34M
Net income -42.54200M -14.85800M -24.18400M -41.90700M
Change in cash -29.01700M 6.84M 24.66M -10.65700M
Begin period cash flow 32.31M 25.47M 0.81M 11.47M
End period cash flow 3.29M 32.31M 25.47M 0.81M
Total cash from operating activities -27.57800M -36.61700M -0.84500M -45.96100M
Issuance of capital stock 0.00000M 34.18M 24.69M 35.77M
Depreciation 0.86M 0.70M 0.28M 0.03M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables - -10.02800M -10.02800M -10.02800M
Sale purchase of stock - - - -
Other cashflows from financing activities - 9.09M 9.09M 9.09M
Change to netincome - -11.92100M 27.97M -17.38800M
Capital expenditures 1.02M 0.37M 0.28M 0.28M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 12.19M -10.53700M -4.91580M 13.30M
Stock based compensation 4.08M 4.04M 1.10M 1.65M
Other non cash items 0.13M -0.34800M -1.07615M 0.74M
Free cash flow -28.59800M -37.37200M -1.44449M -46.41840M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TMDIF
Titan Medical Inc.		 - -% - - - 0.42 2.16 0.39 -0.2281
ABT
Abbott Laboratories		 0.02 0.02% 86.99 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 1.70 0.58% 295.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 4.20 5.69% 77.95 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.01 0.02% 47.69 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.